SN

Saurabh Nanasaheb Jagtap

Active Director Director DIN 09236170
DIN 09236170 First appointment Jul 2021 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Saurabh Nanasaheb Jagtap

Data last updated:

Saurabh Nanasaheb Jagtap is a Director at Salvation Pharma Private Limited (since 2021). The company operates in Machinery and Equipment.

DIN 09236170
Primary Designation Director
Industry Machinery and Equipment
First Appointment 12 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Salvation Pharma Private Limited U24297PN2021PTC202546
Director12 Jul 20212021Active

Directorship timeline

Open interactive timeline →
Salvation Pharma Private Limited
Premium access

Shareholding and investment profile for Saurabh Nanasaheb Jagtap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh Nanasaheb Jagtap

Saurabh Nanasaheb Jagtap currently holds 1 directorship: Salvation Pharma Private Limited (Director, since 12 Jul 2021).

Saurabh Nanasaheb Jagtap was first appointed on 12 Jul 2021 as Director at Salvation Pharma Private Limited.

The current boards of Saurabh Nanasaheb Jagtap's companies include Dhananjay Chandrakant Konde Deshmukh (Salvation Pharma Private Limited), Nagesh Madhukar More (Salvation Pharma Private Limited), Pratik Chandrashekhar Jagtap (Salvation Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available